Tag: Biosciences

Biology

DuPont Nutrition & Biosciences Announces New Distribution Partnership with Interdisp JCS

Newsemia
WILMINGTON, Del. (PRWEB) May 12, 2020 DuPont Nutrition & Biosciences (N&B) has announced the selection of Interdisp JCS as the new distribution partner for all...
Biology

RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the Clinic

Newsemia
FREDERICK, Md. (PRWEB) March 17, 2020 RoosterBio Inc. announces a clinical supply and manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti)...
Biology

Major Infant Health Collaboration Announced by APC Microbiome Ireland with DuPont Nutrition & Biosciences

Newsemia
WILMINGTON, Del. (PRWEB) March 12, 2020 Today, DuPont Nutrition & Biosciences (DuPont) announced a second collaboration with the APC Microbiome Ireland SFI Research Center (APC),...
Biology

ABCT, Connecticut’s Newest Accelerator Program for Biosciences Ventures, Announces 2020 Cohort of Life Science Startups

Newsemia
BRANFORD, Conn. (PRWEB) January 06, 2020 ABCT , the Accelerator for Biosciences in Connecticut, today announced the second cohort of emerging biosciences ventures invited to...
Latest News

Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate VE800 In Combination with Bristol-Myers Squibb’s Opdivo® (Nivolumab)

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences Announces Initiation of First-in-Patient Study of Immuno-Oncology Candidate In Combination with Bristol-Myers Squibb’s Opdivo Source link...
Latest News

Promethera Biosciences Presents Updated Clinical Results at AASLD 2019 for World’s First Stem Cell Therapy Trial using HepaStem™ in Acute-on-Chronic Liver Failure

Newsemia
MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–Promethera presents updated clinical data from a Phase 2a trial (HEP101) of its lead product candidate HepaStem™ at AASLD Source link...
Latest News

Riassunto: Knopp Biosciences riceve un rinnovo per il 4° anno consecutivo del premio NIH Blueprint Grant Award per l’avanzamento di KB-3061, un attivatore di Kv7 in una rara forma di epilessia neonatale

Newsemia
PITTSBURGH–(BUSINESS WIRE)–Knopp Biosciences LLC oggi ha annunciato il rinnovo dell’assegnazione della sua sovvenzione per il 4° anno da parte di National Institutes of Health Blueprint...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World